Document Detail


Anti-rheumatic therapy in patients with rheumatoid arthritis undergoing hemodialysis.
MedLine Citation:
PMID:  22214809     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Hemodialysis (HD) patients have been increasing recently. Some rheumatoid arthritis (RA) patients need hemodialysis (HD), though the proportion is not high. At present, such patients are almost treated with corticosteroids and/or nonsteroidal anti-inflammatory drugs alone, even if they have a high disease activity that would require disease-modifying anti-rheumatic drug (DMARD) therapy, partly because the safety of DMARDs in RA patients with end-stage renal disease has not been confirmed. Their joint destruction would be inevitable and lead to impaired activities of daily living. As there are no guidelines for the use of DMARDs in HD patients, here I reviewed the previous reports about the treatment of DMARDs including biologics for patients with RA undergoing HD.
Authors:
Yuji Akiyama
Related Documents :
17987649 - Factors predicting response to dopaminergic treatment for resting tremor of parkinson's...
20032909 - Evaluation of a patient-specific index as an outcome measure for physiotherapy in parki...
19282209 - Tyrosine hydroxylase deficiency with severe clinical course.
1971459 - Neurologic approach to drug-induced movement disorders: a study of 125 patients.
22198689 - The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis...
17825599 - Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive ...
17427279 - Hemodynamic cerebral ischemia during carotid endarterectomy evaluated by intraoperative...
3734259 - Transcatheter ablative techniques for treatment of the permanent form of junctional rec...
20958919 - Low-molecular-weight heparin in patients with advanced cirrhosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology     Volume:  34     ISSN:  1349-7413     ISO Abbreviation:  Nihon Rinsho Meneki Gakkai Kaishi     Publication Date:  2011  
Date Detail:
Created Date:  2012-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9505992     Medline TA:  Nihon Rinsho Meneki Gakkai Kaishi     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  485-92     Citation Subset:  IM    
Affiliation:
Department of Rheumatology and Applied Immunology Saitama Medical University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immune mechanisms involved in the development and eradication of anti-factor VIII alloantibodies in ...
Next Document:  The effects of disease modifying anti-rheumatic drugs on osteoclastogenesis and bone destruction in ...